Cargando…

MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner

Non-native ligands for growth factor receptors with distinct chemical properties and different biological activities have the potential to become therapeutic applications. We previously generated MET/hepatocyte growth factor (HGF) receptor agonists using bivalent macrocyclic peptides. The highest ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Wenyu, Sakai, Katsuya, Imamura, Ryu, Ito, Kenichiro, Suga, Hiroaki, Sakuma, Tetsushi, Yamamoto, Takashi, Matsumoto, Kunio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213957/ https://www.ncbi.nlm.nih.gov/pubmed/30322054 http://dx.doi.org/10.3390/ijms19103141

Ejemplares similares

Artificial human Met agonists based on macrocycle scaffolds
por: Ito, Kenichiro, et al.
Publicado: (2015)

Cyclic Peptide-Based Biologics Regulating HGF-MET
por: Sato, Hiroki, et al.
Publicado: (2020)

Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist
por: Miao, Wenyu, et al.
Publicado: (2018)

Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
por: Tahira, Yumiko, et al.
Publicado: (2021)

HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014)

Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions
por: Sakai, Katsuya, et al.
Publicado: (2022)

Impaired ligand‐dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer
por: Miao, Wenyu, et al.
Publicado: (2019)

Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma
por: Adachi, Eri, et al.
Publicado: (2016)

Distinct Localization of Mature HGF from its Precursor Form in Developing and Repairing the Stomach
por: Jangphattananont, Nawaphat, et al.
Publicado: (2019)

Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins
por: Mihara, Emiko, et al.
Publicado: (2021)

Technologies for the Synthesis of mRNA-Encoding Libraries and Discovery of Bioactive Natural Product-Inspired Non-Traditional Macrocyclic Peptides
por: Ito, Kenichiro, et al.
Publicado: (2013)

Met receptor is essential for MAVS-mediated antiviral innate immunity in epithelial cells independent of its kinase activity
por: Imamura, Ryu, et al.
Publicado: (2023)

De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
por: Komatsu, Yamato, et al.
Publicado: (2021)

HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Physiological Signaling and Structure of the HGF Receptor MET
por: Baldanzi, Gianluca, et al.
Publicado: (2014)

HGF/MET Signaling in Malignant Brain Tumors
por: Mulcahy, Elizabeth Qian Xu, et al.
Publicado: (2020)

Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies
por: Shinbara, Koki, et al.
Publicado: (2020)

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion
por: Cao, Hui-Hui, et al.
Publicado: (2015)

HGF-independent Potentiation of EGFR Action by c-Met
por: Dulak, Austin M., et al.
Publicado: (2011)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
por: Papaccio, Federica, et al.
Publicado: (2018)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
por: Tada, Yuji, et al.
Publicado: (2015)

Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
por: Nakade, Junya, et al.
Publicado: (2014)

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
por: Owusu, Benjamin Y., et al.
Publicado: (2016)

HGF/c-Met related activation of β-catenin in hepatoblastoma
por: Purcell, Rachel, et al.
Publicado: (2011)

Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
por: You, Jingjing, et al.
Publicado: (2015)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
por: Spina, Anna, et al.
Publicado: (2015)

HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
por: Xiang, Chuan, et al.
Publicado: (2017)

HGF/c-Met: A Key Promoter in Liver Regeneration
por: Zhao, Yang, et al.
Publicado: (2022)

Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET
por: Saunders, Jacquelyn T., et al.
Publicado: (2023)

Role of HGF/c-Met in Serum-Starved ARPE-19 Cells
por: Jun, Eun Jung, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_vhj06hf0njsal0ebr5aggsu400